Experimental mRNA tuberculosis vaccines show strong protection in preclinical studies
27 July 2026
Two experimental mRNA-based tuberculosis (TB) vaccines have demonstrated promising immune responses and protection against Mycobacterium tuberculosis in preclinical studies… Read More…









